CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Smart Money VCs (6328) Pharma Startups (4732)
ARYx Therapeutics is a privately-held pharmaceutical research and development company focused on addressing safety concerns in well-established and commercially successful existing therapies through application of its proprietary ARYx RetroMetabolic ...Show all
Company (IPO / Went public)
Phone: 510-585-2200
6300 Dumbarton Circle
Fremont, 94555
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| ARYX Therapeutics | $132M | Nov 5, 2008 |
| Intarcia Therapeutics | $1513.7M | Apr 3, 2017 |
| TruSource Technologies | $0M | Oct 20, 2018 |
| See all 21 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Materials and methods for the treatment of gastroesophageal reflux disease | Dec 21, 2007 | May 31, 2011 | Patent |
| Ultrashort acting hypnotic barbiturates | Dec 20, 2007 | Apr 27, 2010 | Patent |
| 5-ht3 receptor antagonists and methods of use | Oct 20, 2006 | Mar 10, 2009 | Patent |
Download PDF